NORDITROPIN 40 UI

horm001PHARMACOLOGICAL properties action drug the trials in vitro preclinical and clinical have shown that norditropin lyophilized powder is a therapeutic equivalent to human pituitary-derived growth hormone and reaches in normal adults similar Pharmacokinetic profiles. In pediatric patients (DHC) growth hormone deficiency or with syndrome Prader Willi (SPW), treatment with norditropin stimulates growth and can normalize plasma concentrations of IGF-I (insulin-like growth Factor /Somatomedina C). In adults with DHC, treatment with norditropin increases the ratio of lean body mass and reduces the proportion of body fat, modifies the metabolism with beneficial changes in the metabolism of lipids and normalize IGF-I concentrations. The role of the growth hormone in the human body is intimately connected to the metabolism of carbohydrates, lipids and proteins as well as the process of growth of tissues. Main functions: stimulates protein synthesis, stimulates lipolysis, stimulates ketogenesis, spurs the gluconeogenesis, increases lean body mass, increases skeletal muscle fibers and strength, stimulates the synthesis and release of IGF-I (growth factor).

IGTROPE 1500 IU

horm009Factor of growth IGF-1 is a protein released by many tissues and practically affects almost all cells of the body. The main synths organs of IGF-1 is the liver, although it also occurs locally in the placenta, the heart, lung, kidney, pancreas, spleen, intestine, testes, ovaries, intestine, brain, bone marrow, and pituitary. The production is stimulated by the the growth hormone (GH) and can be retarded by undernutrition, insensitivity to growth hormone, the lack of receptors, hormone of growth, or failures in the signaling path postreceptores (second Messenger) GH including the SHP2 and STAT5B. Approximately 98% of IGF-1 always is linked to one of 6 binding proteins (IGF-BP). IGFBP3, the most abundant protein, represents 80% of all joints of the IGF. IGF-1 binds to IGFBP-3 in a 1:1 molar ratio. This protein forms a ternary complex of 140,000 with IGF-1 and an acida-labil subunit daltons. In experiments with rats, the amount of IGF-1 mRNA in the liver was positively associated with dietary casein and negatively associated with a protein-free diet. [4] recently, was developed an efficient expression of plants to produce human IGF-I biologically active recombinant (rhIGF-I) in transgenic rice grains. [5] human beings produce approximately 30mg of IGF-1 a day up to 30 years of age and from this moment the production decreases with age. Mechanism of action main action is mediated by the union to its specific receptor, the receptor for insulin growth factor type 1, abbreviated as IGF1R, present in many types of tissues.In the union the IGF1R, a receptor tyrosine kinase, initiates intracellular signaling; IGF-1 is one of the most potent natural activators of transduction signal PKB, a stimulator of growth and cell proliferation, and a potent inhibitor of programmed cell death.

DYNATROPE 36UI

horm008PHARMACOLOGICAL properties action drug the trials in vitro preclinical and clinical have shown that dynatrope lyophilized powder is a therapeutic equivalent to human pituitary-derived growth hormone and reaches in normal adults similar Pharmacokinetic profiles. In pediatric patients (DHC) growth hormone deficiency or with syndrome Prader Willi (SPW), treatment with dynatrope stimulates growth and can normalize plasma concentrations of IGF-I (insulin-like growth Factor /Somatomedina C). In adults with DHC, dynatrope treatment increases the ratio of lean body mass and reduces the proportion of body fat, modifies the metabolism with beneficial changes in the metabolism of lipids and normalize IGF-I concentrations. The role of the growth hormone in the human body is intimately connected to the metabolism of carbohydrates, lipids and proteins as well as the process of growth of tissues. Main functions: stimulates protein synthesis, stimulates lipolysis, stimulates ketogenesis, spurs the gluconeogenesis, increases lean body mass, increases skeletal muscle fibers and strength, stimulates the synthesis and release of IGF-I (growth factor).

KIGTROPIN 200UI

скачанные файлы (29)PHARMACOLOGICAL properties action drug the trials in vitro preclinical and clinical have shown that propecia lyophilized powder is a therapeutic equivalent to human pituitary-derived growth hormone and reaches in normal adults similar Pharmacokinetic profiles. In pediatric patients (DHC) growth hormone deficiency or with syndrome Prader Willi (SPW), treatment with propecia stimulates growth and can normalize plasma concentrations of IGF-I (insulin-like growth Factor /Somatomedina C). In adults with DHC, treatment with propecia increases the ratio of lean body mass and reduces the proportion of body fat, modifies the metabolism with beneficial changes in the metabolism of lipids and normalize IGF-I concentrations. The role of the growth hormone in the human body is intimately connected to the metabolism of carbohydrates, lipids and proteins as well as the process of growth of tissues. Main functions: stimulates protein synthesis, stimulates lipolysis, stimulates ketogenesis, spurs the gluconeogenesis, increases lean body mass, increases skeletal muscle fibers and strength, stimulates the synthesis and release of IGF-I (growth factor).

SAIZEN 4UI

скачанные файлы (28)PHARMACOLOGICAL properties action drug the trials in vitro preclinical and clinical have shown that saizen lyophilized powder is a therapeutic equivalent to human pituitary-derived growth hormone and reaches in normal adults similar Pharmacokinetic profiles. In pediatric patients (DHC) growth hormone deficiency or with syndrome Prader Willi (SPW), treatment with saizen stimulates growth and can normalize plasma concentrations of IGF-I (insulin-like growth Factor /Somatomedina C). In adults with DHC, saizen treatment increases the ratio of lean body mass and reduces the proportion of body fat, modifies the metabolism with beneficial changes in the metabolism of lipids and normalize IGF-I concentrations. The role of the growth hormone in the human body is intimately connected to the metabolism of carbohydrates, lipids and proteins as well as the process of growth of tissues. Main functions: stimulates protein synthesis, stimulates lipolysis, stimulates ketogenesis, spurs the gluconeogenesis, increases lean body mass, increases skeletal muscle fibers and strength, stimulates the synthesis and release of IGF-I (growth factor).

XERENDIP 4 IU

скачанные файлы (27)PHARMACOLOGICAL properties action drug the trials in vitro preclinical and clinical have shown that xerendip lyophilized powder is a therapeutic equivalent to human pituitary-derived growth hormone and reaches in normal adults similar Pharmacokinetic profiles. In pediatric patients (DHC) growth hormone deficiency or with syndrome Prader Willi (SPW), treatment with xerendip stimulates the growth and can normalize plasma concentrations of IGF-I (insulin-like growth Factor /Somatomedina C). In adults with DHC, treatment with xerendip increases the ratio of lean body mass and reduces the proportion of body fat, modifies the metabolism with beneficial changes in the metabolism of lipids and normalize IGF-I concentrations. The role of the growth hormone in the human body is intimately connected to the metabolism of carbohydrates, lipids and proteins as well as the process of growth of tissues. Main functions: stimulates protein synthesis, stimulates lipolysis, stimulates ketogenesis, spurs the gluconeogenesis, increases lean body mass, increases skeletal muscle fibers and strength, stimulates the synthesis and release of IGF-I (growth factor).

16 C GENOTROPIN UI

скачанные файлы (26)PHARMACOLOGICAL properties action drug the trials in vitro preclinical and clinical have shown that genotropin lyophilized powder is a therapeutic equivalent to human pituitary-derived growth hormone and reaches in normal adults similar Pharmacokinetic profiles. In pediatric patients (DHC) growth hormone deficiency or with syndrome Prader Willi (SPW), treatment with genotropin stimulates growth and can normalize plasma concentrations of IGF-I (insulin-like growth Factor /Somatomedina C). In adults with DHC, treatment with genotropin increases the ratio of lean body mass and reduces the proportion of body fat, modifies the metabolism with beneficial changes in the metabolism of lipids and normalize IGF-I concentrations. The role of the growth hormone in the human body is intimately connected to the metabolism of carbohydrates, lipids and proteins as well as the process of growth of tissues. Main functions: stimulates protein synthesis, stimulates lipolysis, stimulates ketogenesis, spurs the gluconeogenesis, increases lean body mass, increases skeletal muscle fibers and strength, stimulates the synthesis and release of IGF-I (growth factor).

SOMATROPE 50 UI

скачанные файлы (25)PHARMACOLOGICAL properties action drug the trials in vitro preclinical and clinical have shown that SOMATROPE lyophilized powder is a therapeutic equivalent to human pituitary-derived growth hormone and reaches in normal adults similar Pharmacokinetic profiles. In pediatric patients (DHC) growth hormone deficiency or with syndrome Prader Willi (SPW), treatment with SOMATROPE stimulates growth and can normalize plasma concentrations of IGF-I (insulin-like growth Factor /Somatomedina C). In adults with DHC, SOMATROPE treatment increases the ratio of lean body mass and reduces the proportion of body fat, modifies the metabolism with beneficial changes in the metabolism of lipids and normalize IGF-I concentrations. The role of the growth hormone in the human body is intimately connected to the metabolism of carbohydrates, lipids and proteins as well as the process of growth of tissues. Main functions: stimulates protein synthesis, stimulates lipolysis, stimulates ketogenesis, spurs the gluconeogenesis, increases lean body mass, increases skeletal muscle fibers and strength, stimulates the synthesis and release of IGF-I (growth factor).

DYNALAN 1300MCG

скачанные файлы (24)Factor of growth IGF-1 is a protein released by many tissues and practically affects almost all cells of the body. The main synths organs of IGF-1 is the liver, although it also occurs locally in the placenta, the heart, lung, kidney, pancreas, spleen, intestine, testes, ovaries, intestine, brain, bone marrow, and pituitary. The production is stimulated by the the growth hormone (GH) and can be retarded by undernutrition, insensitivity to growth hormone, the lack of receptors, hormone of growth, or failures in the signaling path postreceptores (second Messenger) GH including the SHP2 and STAT5B. Approximately 98% of IGF-1 always is linked to one of 6 binding proteins (IGF-BP). IGFBP3, the most abundant protein, represents 80% of all joints of the IGF. IGF-1 binds to IGFBP-3 in a 1:1 molar ratio. This protein forms a ternary complex of 140,000 with IGF-1 and an acida-labil subunit daltons. In experiments with rats, the amount of IGF-1 mRNA in the liver was positively associated with dietary casein and negatively associated with a protein-free diet. [4] recently, was developed an efficient expression of plants to produce human IGF-I biologically active recombinant (rhIGF-I) in transgenic rice grains. [5] human beings produce approximately 30mg of IGF-1 a day up to 30 years of age and from this moment the production decreases with age. Mechanism of action main action is mediated by the union to its specific receptor, the receptor for insulin growth factor type 1, abbreviated as IGF1R, present in many types of tissues.In the union the IGF1R, a receptor tyrosine kinase, initiates intracellular signaling; IGF-1 is one of the most potent natural activators of transduction signal PKB, a stimulator of growth and cell proliferation, and a potent inhibitor of programmed cell death.